403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Medicenna Therapeutics Corp
(MENAFN- Baystreet) 10:47 AM EST - Medicenna Therapeutics Corp : Today announced a grant of five patents covering the Company's IL-2 and IL-4 Superkine platforms. These patents strengthen Medicenna's intellectual property (IP) position across key markets and further support the Company's lead clinical and preclinical programs. Medicenna Therapeutics Corp
shares T are trading up $0.02 at $0.88.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Tappalpha's Flagship ETF, TSPY, Surpasses $100 Million In AUM
- Schoenherr Opens London Liaison Office As Gateway To Central Eastern Europe
- Daytrading Publishes New Study Showing 70% Of Viral Finance Tiktoks Are Misleading
- Forex Expo Dubai 2025 Conference To Feature 150+ Global FX And Fintech Leaders
- Falcon Finance Unveils $FF Governance Token In Updated Whitepaper
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
More Story
Comments
No comment